Long-term outcomes of infliximab in a real-world multicenter cohort of patients with acute severe ulcerative colitis

BACKGROUND/AIMS: Infliximab (IFX) has proven effective as rescue therapy in steroid-refractory acute severe ulcerative colitis (ASUC), however, the long-term real-world data are scarce. Our study aimed to assess the long-term treatment outcomes of IFX in a real-life cohort. METHODS: We established a...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Shin Ju, Shin, Ga Young, Soh, Hosim, Lee, Jae Gon, Im, Jong Pil, Eun, Chang Soo, Lee, Kang-Moon, Park, Dong Il, Han, Dong Soo, Kim, Hyo Jong, Lee, Chang Kyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322032/
https://www.ncbi.nlm.nih.gov/pubmed/32806875
http://dx.doi.org/10.5217/ir.2020.00039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322032/
https://www.ncbi.nlm.nih.gov/pubmed/32806875
http://dx.doi.org/10.5217/ir.2020.00039

Ejemplares similares